We report here the first full-length sequence of the eight ssRNA genome segments of the infectious salmon anemia virus (ISAV, Glesvaer/2/90 isolate), a salmonid orthomyxovirus-like.
Infectious salmon anemia (ISA) was first observed in Norway from Atlantic salmon (Salmo salar L.) in 1984 (Thorud & Djupvik, 1988) . ISA outbreaks have since caused considerable economic losses to the Norwegian salmon farming industry and have also been reported in Scotland (Rowley et al., 1999) , in the eastern coast of Canada (Bouchard et al., 1999; Lovely et al., 1999) and has been associated with extensive outbreaks in Chile since June 2007 (Godoy et al., 2008) . The mortality rate in contaminated salmon farms may vary from 15 to 100 % over several months. Although, ISA virus (ISAV) outbreaks were observed only in Atlantic salmon, the virus was detected from apparently healthy animals in other species (Raynard et al., 2001) . The only exception was the isolation of ISAV from diseased Coho salmon (Oncorhynchus kisutch) in Chile in 1999 (Kibenge et al., 2001) . Experimental infections showed that other species could be susceptible to ISAV infection, especially juvenile rainbow trout (Oncorhynchus mykiss) for which mortality was recorded after both virus injection and bath immersion, which may represent a threat to the trout industry (Biacchesi et al., 2007) .
The aetiological agent of ISA was identified as an orthomyxovirus-like with a negative-stranded RNA genome consisting of eight segments (Dannevig et al., 1995; Falk et al., 1997; Mjaaland et al., 1997) , and constitutes the only member of the genus Isavirus (Kawaoka et al., 2005) . ISAV is an enveloped virus composed of four major structural proteins: the nucleoprotein (66-72 kDa), the matrix protein (22-25 kDa) and two envelope glycoproteins that are the haemagglutinin-esterase glycoprotein (42 kDa) and the fusion protein (47-50 kDa) (Clouthier et al., 2002; Falk et al., 2004) . Sequence characterization of ISAV genome segments is almost fully achieved, except for several segment end UTRs (Sandvik et al., 2000) . It is now evident that the gene coding assignment to each segment and the putative functions of the ISAV proteins are unique and significantly different from those of other orthomyxoviruses. The ISAV genome encodes at least 10 proteins. ISAV genome segments 1-6 encode one protein each and by analogy to other orthomyxoviruses and additional characterizations, the ISAV proteins are as follows: PB2, component of RNA polymerase (Snow et al., 2003) ; PB1, RNA-dependent RNA polymerase core motif (Krossoy et al., 1999) ; NP, nucleoprotein (Aspehaug et al., 2004; Ritchie et al., 2001; ); PA; component of RNA polymerase (Ritchie et al., 2001) ; F, fusion protein (Aspehaug et al., 2005; Clouthier et al., 2002) , and HE, haemagglutininesterase glycoprotein containing both receptor-binding and receptor-destroying enzyme domains (Hellebo et al., 2004; Kristiansen et al., 2002; Krossoy et al., 2001; Rimstad et al., 2001 ). Similar to influenza viruses, the two smallest ISAV genome segments encode at least two proteins each. Segment 7 produces a collinear transcript mRNA (S7 ORF1) encoding an antagonist of type I interferon (IFN) response, whereas S7 ORF2 protein, identified as a putative nuclear export protein, is encoded by a spliced mRNA (Bierin et al., 2002; Garcia-Rosado et al., 2008; Kibenge et al., 2007; McBeath et al., 2006; Ritchie et al., 2002) . Segment 8 produces an mRNA transcript containing two overlapping ORF. The smaller ORF1 encodes the matrix protein (M) and the S8 ORF2 was recently shown to be involved in the modulation of type I IFN response together with S7 ORF1 (Bierin et al., 2002; Garcia-Rosado et al., 2008) .
In the present study, we used the ISAV Glesvaer/2/90 isolate amplified by passages onto the salmonid-derived cell line TO (Wergeland & Jakobsen, 2001 ) maintained in L15 medium (Invitrogen) in the absence of FBS at 15 u C (Dannevig et al., 1995) . To determine the complete nucleotide sequence of the eight ISAV genomic RNA segments, viral RNA (vRNA) was extracted from a low passage virus stock using QIAamp viral RNA purification kit (Qiagen). vRNA was mixed with 50 pmol of each primer designed from the sequences available in GenBank and incubated for 8 min at 70 u C. Reverse transcription with Superscript II enzyme (Invitrogen) was performed at 42 u C for 45 min and at 52 u C for 20 min to minimize the formation of RNA secondary structure. PCR was performed with Platinum Pfx DNA polymerase (Invitrogen). Nucleotide sequences of cDNA products were determined by direct sequence analysis of the RT-PCR products. To sequence the 39 end of each ISAV genome segment, in vitro polyadenylated vRNA was converted into cDNA and amplified using the Smart RACE cDNA amplification kit (BD Clontech) with universal primers provided by the manufacturer and ISAV-specific primers. Then, RACE products were sequenced directly after purification with a QIAquick PCR purification kit (Qiagen). To sequence the 59 end of the ISAV genome segments, vRNA was processed by first-strand cDNA synthesis using a specific primer of each segment in the presence of SMART II A oligonucleotide (BD Clontech) that serves as an extended template for murine leukemia virus reverse transcriptase. Then, PCR was performed using an internal ISAV-specific primer for each segment and a UPM primer supplied with the kit. Finally, the amplified cDNAs were sequenced directly.
The ISAV Glesvaer/2/90 genome total length was found to be 13227 nt and very similar to that of influenza virus A/ PR/8/34 with its 13588 nt in length (for details see Supplementary Table S1 , available in JGV Online). Amino acid sequences of each ORF encoded by each segment were mainly identical to those available in GenBank for this strain and closely related strains . The most conserved proteins between ISAV and influenza virus A/PR/8/34 are PB1 proteins although they share only 31 % amino acid similarity. 59-RACE amplification confirmed the production of a spliced mRNA from segment 7 mRNA ORF1 that encodes the S7 ORF2, as previously published (Bierin et al., 2002; Ritchie et al., 2002) (data not shown). It is to be noted that the ISAV segment 7 ends, previously published by Sandvik et al. (2000) , were found to be segment 6 ends. The nucleotide sequences of the 39 and 59 end UTR of all eight segments of ISAV were determined and aligned as shown in Fig. 1 . The 39 UTR sequences were surprisingly not highly conserved since only six nucleotides at the 39 termini were common to all the segments, contrasting with influenza A virus (IAV; A/PR/8/34 isolate) for which 11 of the 12 first nucleotides at the 39 termini are common to all the segments. A moderate sequence identity could be found between ISAV 39 UTR and those from other orthomyxoviruses. Moreover, ISAV 39 UTRs were found to be extremely variable in length (7-48 nt) with three of the eight segments displaying only 7-9 nt upstream of the start codon. For comparison, the IAV 39 UTR of each segment varies in length from 20 to 45 nt. In contrast, the ISAV 59 UTR were extremely long with 67-147 nt in length compared with 20-58 nt for IAV. Only 10 of the 21 extreme nucleotides at the 59 termini were common to all ISAV segments compared with 17 nt for all IAV segments. These 21 extreme nucleotides of the 59 termini present a uridine-rich region that serves as polyadenylation signal, which was shorter for ISAV segments than those of IAV (3-5 versus 5-6 uridines, respectively). Despite the shorter size of the uridine-rich region in ISAV segments, the position of these regions correlates with the beginning of the polyadenosine tail found in the 39 ends of the mRNA sequences available in GenBank. The most interesting characteristic of the ISAV 59 UTR was the presence of a conserved motif in all segments upstream of the polyadenylation signal, which was not found in other orthomyxoviruses: C(N) 3 AACU(N) 3 A. Finally, as described for IAV, the 39-and 59-terminal sequences of each segment showed partial and inverted complementarity (data not shown).
To generate mAbs specific for ISAV, six-week-old BALB/c mice were immunized with sucrose-gradient purified virus from a pool of infected-TO cell supernatants (approx. 120 ml) as described previously (Moriette et al., 2005) . Four specific anti-ISAV secreting hybridomas were selected by testing their culture supernatants by indirect fluorescent antibody test (IFAT) against mock-and ISAV-infected cells. After subcloning these four positive hybridomas, ascite fluids were produced. The reactivity of these mAbs was tested by IFAT on ISAV-infected cells. TO cells were infected at a low m.o.i., and 3 days post-infection cells were incubated either after fixation with alcohol/acetone ( Fig.  2a; fixed cells) or directly ( Fig. 2b ; live cells) with the mAbs. On mock-and ISAV-infected TO cells fixed and permeabilized, the four mAbs, namely B1, B23, B24 and E14, were found to be highly specific for ISAV proteins with optimal dilutions of 1 : 2500, 1 : 10 000, 1 : 5000 and 1 : 25 000, respectively (Fig. 2a) . Only the B23 mAb was reactive on infected live cells (Fig. 2b) and thus was supposed to recognize an ISAV protein exposed on the external side of the cell membrane. B23 mAb displays a strong neutralizing activity (neutralizing titre of 1 : 10 000 not shown). Depending on the mAb used the fluorescence pattern observed differed. B23 mAb exhibited staining at the cellular membrane that clearly underlined the cellular projections together with a diffuse staining of the cytoplasm. In contrast, B1 mAb recognized a viral protein located both in the nucleus and in the cytoplasm of the infected cells. B24 and E14 mAbs exhibited staining mainly in the cytoplasm and to a lesser extent compared with B1 in some nucleus. In the cytoplasm, B24 mAb detected a viral protein strongly accumulated around the nucleus and in some infected cells, round perinuclear structures could be observed (Fig. 2c) . In contrast, E14 mAb displayed staining throughout the cytoplasm and on the interior side of the cellular membrane that seems to co-localize in part with the cellular microskeleton (Fig. 2c) . Finally, to characterize the viral protein recognized by each mAb, TO cells were transfected with eukaryotic expression vectors pcDNA1.1/ Amp (Invitrogen) encoding the full set of ISAV proteins cloned from individual RT-PCR products. The overlapping ORFs of segment 8 encoding M1 and M2 were amplified using specific primers in which the ATG start codon of the alternative ORF was removed by a silent mutation (Supplementary Table S2 , available in JGV Online). As shown in Fig. 2(c) , a similar fluorescence pattern could be observed after transfection of the targeted viral protein alone compared with that obtained on ISAV-infected cells (Fig. 2a) for each mAb. As expected from the above observations, B23 mAb recognized a viral envelope protein (HE). B1 mAb was specific to the NP protein, which is in agreement with its nuclear and cytoplasmic staining. Surprisingly, B24 and E14 mAbs were directed against the matrix M protein despite exhibiting a different staining.
To determine if E14 mAb recognizes a cytoskeletalassociated form of M protein, mock- (Fig. 2d) or ISAVinfected TO cells (Fig. 2e) at 3 days post-infection were stained for actin filaments as well as for M. M and actin filaments exhibited strong co-localization, especially at the interior side of the cellular membrane. Similar distribution of M could be observed in cells transfected with M alone (Fig. 2c , panel E14/M1 and data not shown), excluding any participation of other viral proteins for M-actin filament co-localization. Thus, these results suggest an interaction of the M protein with actin filaments.
The reactivity of the four ISAV mAbs was evaluated through various assays. The four mAbs were tested first for their reactivity by Western blot against either sucrosepurified ISAV or total lysates from mock-or ISAV-infected TO cells. The left panel of Fig. 3(a) illustrates the protein profile of sucrose-gradient purified virion directly visualized by Coomassie blue staining after separation on a polyacrylamide gel. This profile is composed of four major structural proteins: the NP (68 kDa), the matrix M (22 kDa) and the two envelope glycoproteins HE (42 kDa) and F (49 kDa), as described previously (Clouthier et al., 2002; Falk et al., 2004) . It can be seen by the Western blot analysis that the B1, E14 and B24 mAbs were reactive against sucrose-gradient purified virion and ISAV-infected cell lysates as well, and recognized NP and M proteins, respectively, as previously characterized by IFAT. No background was detected in mock-infected lysates. The B23 mAb failed to detect HE in Western blot under reducing and denaturing conditions. However, in nonreducing and non-denaturing conditions, an HE-specific band was detected by B23 mAb at least with the sucrosegradient purified virion sample (Fig. 3b) . Notably, B23 mAb only reacts with the monomeric form of HE and does not recognize the multimeric forms of HE as previously visualized after immunoprecipitation of radiolabelled-ISAV virions with an anti-HE mAb (Falk et al., 2004) . These mAbs were then tested for their ability to immunoprecipitate ISAV proteins from [
35 S]methionine radiolabelled virus-infected cell lysates (Fig. 3c ). B1 and B23 mAbs against NP and HE, respectively, recognized proteins of expected molecular mass (approx. 68 and 43 kDa, respectively). For the two mAbs against M, only E14 was reactive in an immunoprecipitation assay. No protein could be detected with any mAbs when mockinfected radiolabelled cell lysates were used.
In this study, we have presented for the first time the complete genome nucleotide sequence for an ISAV isolate. Knowledge of the non-coding 39 and 59 end sequences is an absolute prerequisite for the elaboration of a functional reverse genetics system for this atypical orthomyxovirus. In addition, we have generated and characterized mAbs against some of the ISAV proteins that might be very useful for the development of diagnostic tools for this salmonid virus. Characterization of the receptor-destroying enzyme activity from infectious salmon anaemia virus. J Gen Virol 83, 2693-2697. Krossoy, B., Hordvik, I., Nilsen, F., Nylund, A. & Endresen, C. (1999) .
The putative polymerase sequence of infectious salmon anemia virus suggests a new genus within the Orthomyxoviridae. J Virol 73, 2136-2142. 
